癌に関連した線維細胞におけるNNMT抑制は,抗腫瘍免疫を回復させる
Janna Heide1, Agnes J Bilecz1, Samarjit Patnaik2
1Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, IL, USA.
Nature
|July 23, 2025
まとめ
ニコチナミドNメチルトランスフェラーゼ (NNMT) は免疫抑制細胞を誘発することで癌を助長する. 癌に関連した線維芽細胞 (CAF) のNNMT抑制は,抗腫瘍免疫を高め,腫瘍の成長を抑制し,新しい治療戦略を提供します.
科学分野:
- 腫瘍学
- 免疫学
- 分子生物学
背景:
- 癌に関連した線維細胞 (CAF) は腫瘍の進行において重要な役割を果たします.
- CAFをターゲットにすることは,がん治療における課題です.
研究 の 目的:
- ニコチナミドN-メチルトランスフェラーゼ (NNMT) の高度卵巣がんにおける作用を調査する.
- 癌治療の潜在的治療標的としてNNMTを特定する.
主な方法:
- 空間トランスクリプトミクスと単細胞RNA配列解析を用いた.
- NNMTの役割は,卵巣,乳がん,結腸がんのシンゲニックマウスモデルで評価されました.
- 高通量スクリーニングはNNMT阻害剤を特定するために使用されました.
主要な成果:
- NNMTは,CAFにおけるH3K27me3低甲基化を誘導し,免疫抑制因子の分泌と骨髄系由来抑制細胞 (MDSC) の募集につながる.
- NNMTのノックアウトは複数のがんモデルで腫瘍の成長を阻害し,CD8+T細胞の活性化を強めた.
- 新しいNNMT阻害剤は腫瘍の負荷,転移を軽減し,抗腫瘍免疫を回復させた.
結論:
- NNMTは,腫瘍の微小環境内のCAFと免疫抑制の主要な調節剤です.
- NNMTを標的とした治療は,抗腫瘍免疫を強化し,治療抵抗性を克服するための有望な治療戦略です.
さらに関連する動画
関連する概念動画
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


